IL-23 in the pathogenesis of rheumatoid arthritis

Scandinavian Journal of Immunology

Volumn 71, Issue 3, 2010, Pages 134-145

  Paradowska Gorycka, A ^a   Grzybowska Kowalczyk, A ^a   Wojtecka Lukasik, E ^a   Maslinski, S ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23; INTERLEUKIN 6; JANUS KINASE 2; PROTEIN KINASE TYK2; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL SURVIVAL; DENDRITIC CELL; DISEASE COURSE; ENZYME ACTIVATION; GENETIC POLYMORPHISM; HELPER CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MONOCYTE; NONHUMAN; OSTEOCLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH17 CELL;

ADULT; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHILD; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-23; JANUS KINASE 2; MACROPHAGES; MALE; MICE; MIDDLE AGED; MONOCYTES; OSTEOCLASTS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; TYK2 KINASE;

EID: 77449123423     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02361.x     Document Type: Review

References (102)

1. Kim HR, Cho ML, Kim KW et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by Il-17 through PI3-kinase, NF-κB and p38 MAPK-dependent signaling pathways. Rheumatology 2007 46 : 57 64.
2. Paradowska A, Maslinski W, Grzybowska-Kowalczyk A, Lacki J. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp 2007 55 : 329 334.
3. Bingham CO. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol 2002 29 (Suppl. 65 3 9.
4. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 2005 72 : 1037 1047.
5. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008 118 : 3537 3541.
6. Lupardus PJ, Garcia CK. The structure of interleukin-23 reveals the molecular BASIC of p40 subunit sparing with IL-12. J Mol Biol 2008 382 : 931 941.
7. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003 278 : 1910 1914.
8. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005 201 : 233 240.
9. Hue S, Ajern P, Buonocore S et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006 203 : 2473 2483.
10. Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006 203 : 2673 2682.
11. Wendling D. Interleukin 23: a key cytokine in chronic inflammatory disease. Joint Bone Spine 2008 75 : 517 519.
12. Kim HR, Kim HS, Park MK, Cho ML, Kim HY. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand J Rheumatol 2007 36 : 259 264.
13. Goriely S, Goldman M. Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant 2008 13 : 4 9.
14. Boulay JL, O'Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003 19 : 159 163.
15. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to from a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 13 : 715 725.
16. Niedbala W, Wei X, Cai B et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007 37 : 3021 3029.
17. Del Vecchio M, Bajetta E, Canova S et al. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007 13 : 4677 4685.
18. Villarino AV, Hunter CA. Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res Ther 2004 6 : 225 233.
19. Goriely S, Goldman M. The interleukin-12 family: new players in transplantation immunity? Am J Transplant 2007 7 : 278 284.
20. Yoshimoto T, Owaki T, Asakawa M, Morishima N, Kamiya S, Mizuguchi J. A novel IL-6/IL-12 family cytokine IL-27 and its antitumor activity. Gene Ther Biol 2005 9 : 7 14.
21. Yang J, Yang M, Htut TM et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORγt. Eur J Immunol, 2008 38 : 1204 1214.
22. Gerosa F, Baldani-Guerra B, Lyakh LA et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med 2008 205 : 1447 1461.
23. Beyer BM, Ingram R, Ramanathan L et al. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody. J Mol Biol 2008 382 : 942 955.
24. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 from a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997 94 : 12041 12046.
25. Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002 168 : 5699 5708.
26. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003 73 : 49 56.
27. Brentano F, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D. Abundant expression of the interleukin (IL) 23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis 2008 68 : 143 150.
28. Happel KI, Zheng M, Young E et al. Cutting Edge: roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumonia infection. J Immunol 2003 170 : 4432 4436.
29. Langrish CL, McKenzie BS, Wilson NJ, Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004 202 : 96 105.
30. Zhang Z, Andoh A, Yasui H et al. Interleukin-beta and tumor necrosis factor-alpha upregulated interleukin-23 subunit p19 gene expression in human colonic subthelial myofibroblasts. Int J Mol Med 2005 15 : 79 83.
31. Liu FL, Chen CH, Chu SJ et al. Interleukin (IL)-23 p19 expression induced by IL-1β in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-κB and AP-1 dependent pathway. Rheumatology 2007 46 : 1266 1273.
32. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 2004 18 : 1318 1320. (Pubitemid 39561589)
33. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell response. Immunity 2003 19 : 641 644.
34. Ahern PP, Izcue A, Maloy KJ, Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol Rev 2008 226 : 147 159.
35. Re F, Strominger JL. Toll-like receptor2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001 276 : 37692 37699.
36. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008 180 : 5625 5635.
37. Takatori H, Kanno Y, Chen Z, O'Shea JJ. New complexities In helper T cell fate determination and the implications for autoimmune disease. Mod Rheumatol 2008 18 : 533 541.
38. Fahey AJ, Robins RA, Kindle KB, Heery DM, Constantinescu CS. Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent. J Leukoc Biol 2006 80 : 133 144.
39. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006 18 : 349 356.
40. Yang XO, Panopoulos AD, Nurieva R et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007 282 : 9358 9363.
41. Boniface K, Blom B, Liu YJ, Malefyt R. From interluekin-23 to T-helper 17 cells: human T-helepr cell differentiation revisited. Immunol Rev 2008 226 : 132 146.
42. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008 31 : 252 256.
43. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009 39 : 469 477. Epub 2009 Feb 13.
44. Day MJ. Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation. Vet Parasitol 2007 147 : 2 8. Epub 2007 April 27.
45. Ivanov II, McKenzi BS, Zhou L et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17 T helper cells. Cell 2006 126 : 1121 1133.
46. Mathur AN, Chang HC, Zisoulis DG et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007 178 : 4901 4907.
47. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007 19 : 409 417.
48. Cho ML, Kang JW, Moon YM et al. STAT3 and NF-κB signal pathways is required for IL-23-mediated IL-17 production In spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006 176 : 5652 5661.
49. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006 441 : 235 238.
50. Layh-Schmitt G, Colbert RA. The interleukin-23/interleukin-17 axis in spondyloarthritis. Curr Opin Rheumatol 2008 20 : 392 397.
51. Romagnani S. Human Th17 cells. Arthritis Res Ther 2008 10 : 206.
52. Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008 453 : 236 240.
53. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008 133 : 774 787.
54. Izcue A, Hue S, Buonocore S et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008 28 : 559 570.
55. Liao JJ, Huang MC, Goetzl EJ. Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphatase. J Immunol 2007 178 : 5425 5428.
56. Cua DJ, Sherlock J, Chen Y et al. Inerleukin-23 tarher than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003 421 : 706 708.
57. Murphy CA, Langirsh CL, Chen Y et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003 198 : 1951 1957.
58. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006 116 : 1218 1222.
59. Shahrara S, Huang Q, IL AM, Pope RM. Th-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008 10 : R93.
60. Steinman L. A brief history of Th17, the first major revision in the Th1/Th2 hypothesis of T cell-mediated tissue damage. Nat Med 2007 13 : 139 145.
61. Chen Y, Langrish CL, McKenzie B et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006 116 : 1317 1326.
62. Zhou L, Ivanov II, Spolski R et al. IL-6 programs T(h)-17 cell differentiation by promoting sequential engagement of the IL-12 and IL-23 pathways. Nat Immunol 2007 8 : 967 974.
63. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007 204 : 1849 1861.
64. Buch M, Emery P. The aethiology and pathogenesis of rheumatoid arthritis. Hospital Pharmacist 2002 9 : 5 10.
65. Wiekowski MT, Leach MW, Evans EW et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol 2001 166 : 7563 7570.
66. Belladonna ML, Renauld JC, Bianchi R et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J Immunol 2002 168 : 5448 5454.
67. Happel KI, Dubin PJ, Zheng M et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumonia. J Exp Med 2005 202 : 761 769.
68. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemie anti-Candida albicans host defense in mice. J Infect Dis 2004 190 : 624 631.
69. Lieberman LA, Cardillo F, Owyang AM et al. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol 2004 173 : 1887 1893.
70. Khader SA, Pearl JE, Sakoamoto K et al. IL-23 compenstaes for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis bu is dispensable for protection and antigen-specyfic IFN-γ response if IL-12p70 is available. J Immunol 2005 175 : 788 795.
71. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K. IL-23 promotes tumour incidence and growth. Nature 2006 442 : 461 465.
72. Meeran SM, Katiyar S, Elmets CA, Katiyar SK. Interleukin-12-deficiency is permissive for angiogenesis in UV radiation-induced skin tumors. Cancer Res 2007 67 : 3785 3793.
73. Akil M, Amos RS. ABC of rheumatology: rheumatoid arthritis - I: clinical features and diagnosis. BMJ 1995 310 : 587 590.
74. Chabaud M, Durand JM, Buchs N et al. Human interleukin-17. Arthritis Rheum 1999 42 : 963 970.
75. Kehlen A, Pachnio A, Thiele K, Langner J. Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res Ther 2003 5 : R186 92.
76. Mimori T. Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 2005 44 : 122 1126.
77. Weyand CM, Goronzy JJ. Pathomechanism in rheumatoid arthritis-time for a string theory? J Clin Invest 2006 116 : 869 872.
78. Sangha O. Epidemiology of rheumatic disease. Rheumatology 2000 39 (Suppl. 2 3 12.
79. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002 4 (Suppl. 3 S265 72.
80. Reveille JD. Genetics studies in the rheumatic disease: present status and implications for the future. J Rheumatol 2005 32 (Suppl. 72 10 3.
81. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008 47 : 399 402.
82. van der Helm-van Mil A, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008 10 : 205.
83. Turesson C, Weyand CM, Matteson EL. Genetics of rheumatoid arthritis; Is there a pattern predicting extraarticular manifestations? Arthritis Rheum 2004 51 : 853 863.
84. Aarvak T, Chabaud M, Miossec P, Natving JB. Il-17 is produced by some proinflammatory Th1/Th0 cells but not Th2 cells. J Immunol 1999 162 : 1246 1251.
85. Chen L, Wei XQ, Evans B, Jiang W, Aeschlimann D. IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells. Eur J Immunol 2008 38 : 2845 2854.
86. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collage-induced arthritis In IL-17-deficient mice. J Immunol 2003 171 : 6173 6177.
87. Kotake S, Udagawa N, Takahashi N et al. Il-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999 103 : 1345 1352.
88. Nistala K, Wedderburn LR. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology 2009 48 : 602 606.
89. Stamp LK, Easson A, Pettersson L, Highton J, Hessian PA. Monocyte derived interleukin (IL)-23 expression is an important determination of synovial IL-17A expression in rheumatoid arthritis. J Rheumatol 2009 36 : 2403 2408.
90. Kageyama Y, Kobayashi H, Kato N. Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis. Mod Rheumatol 2009 19 : 657 662.
91. Koshy PJ, Henderson N, Logan C, Life PF, Cawston TE, Rowan AD. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 2002 61 : 704 713.
92. Chabaud M, Lubberts E, Joosten L, van der Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 2001 3 : 168 177.
93. Koenders MI, Lubberts E, Oppers-Walgreen B et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 2005 167 : 141 149.
94. Karaderi T, Harvey D, Farrar C et al. Association between the interleukin 23 receptor and ankylosing spondylitis in confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology 2009 48 : 386 389.
95. Safrany E, Pazar B, Csongei V et al. Variants of the IL-23R gene are associated with ankylosing spondylitis but not with sjorgen syndrome in Hungarian population samples. Scand J Immunol 2009 70 : 68 74.
96. Huffmeier U, Lascorz J, Bohm B et al. Genetic variants of the IL-23 R pathways: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009 129 : 355 358.
97. Dubinsky MC, Wang D, Picornell Y et al. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis 2007 13 : 511 515.
98. Ban Y, Tozaki T, Taniyama M et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 2009 42 : 126 130.
99. Hollis-Moffatt JE, Marriman ME, Rodger RA et al. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Ann Rheum Dis 2009 68 : 1340 1344.
100. Takaku T, Calado RT, Kajigaya S, Young NS. Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anaemia. Ann Hematol 2009 88 : 653 657.
101. Orozco G, Rueda B, Robledo G, Garcia A, Martin J. Investigation of the IL-23R gene In a Spanish rheumatoid arthritis cohort. Hum Immunol 2007 68 : 681 684.
102. Park JH, Kim YJ, Park BL, Bae JS, Shin HD, Bae SC. Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility. Rheumatol Int 2009 29 : 781 786.